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Background: It has been demonstrated that administration of T-type calcium channel (TCC) inhibitors could relieve
the neuropathic pain by intraperitoneally or intrathecally. TCCs are not only expressed in dorsal root ganglia or
dorsal horn, but also in some of the pain associated brain regions. In the present study, we sought to investigate
whether modulating TCCs in the anterior cingulate cortex (ACC) could alleviate the neuropathic pain.
Results: (1) Cav3.2 was up regulated in rat ACC after chronic constriction injury (CCI). (2) T-type calcium current intensity
was increased in CCI animal model. (3) TCC inhibitor reduced miniature excitatory postsynaptic currents frequency of
ACC neurons in CCI animal model. (4) TCC inhibitor suppressed the firing rate of ACC neurons in CCI animal model.
(5) Both mechanical and thermal allodynia were partially relieved by ACC microinjection with TCC inhibitor.
Conclusions: TCCs in the ACC may be contributing to the maintenance of neuropathic pain, and the neuropathic
pain can be alleviated by inhibiting the neuronal activity of ACC through modulating the TCCs.
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Central sensitization is an important mechanism of per-
sistent neuropathic pain. Nociceptive neurons in the
dorsal horns of the spinal cord are reported to become
sensitized by peripheral tissue damage or inflammation
[1]. Further study reveals that pain perception is associ-
ated with activity in many parts of the brain, including
the thalamus, hypothalamus, midbrain, lentiform nucleus,
somatosensory cortices, insula, prefrontal cortex, and
anterior and parietal cingulum [2].
The anterior cingulate cortex (ACC) is the frontal part
of the cingulum that resembles a “collar” surrounding
the frontal part of the corpus callosum. The ACC is
involved in rational cognitive functions such as reward
anticipation, decision-making, empathy, impulse control,
and emotion [3,4]. The ACC is also reported as a key* Correspondence: wangyingwei@yahoo.com
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unless otherwise stated.cortical region involved in the persistent neuropathic
pain [5,6]. Disruption of long-term potentiation in the
ACC can relieve neuropathic pain [7]. Moreover, our pre-
vious work has demonstrated that neuronal activity in the
ACC is upregulated in animal model of neuropathic pain
[8]. These studies suggest that inhibiting the neuronal
activity of the ACC may alleviate neuropathic pain.
T-type calcium channels (TCCs) are a type of low
threshold voltage-gated ion channel, and they are im-
portant for the repetitive firing of action potentials in
neurons with rhythmic firing patterns [9]. TCC-mediated
burst firing activates cortical neurons more efficiently than
tonic firing, potentially providing further amplification
of the thalamocortical relay of sensory signals [10-12].
Thus, this neuronal activity may be inhibited by modu-
lating TCCs. We therefore sought to investigate whether
the neuropathic pain could be alleviated by inhibiting
the neuronal activity of the ACC through modulating
the TCCs.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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The expression of TCC RNA was upregulated in rat ACC
after chronic constriction injury
Kang et al. have mentioned that TCCs are expressed in
mouse ACC [13]. However, no further information about
the functions of TCC in the ACC is available from that
study or any other reports. TCCs may contain one of
three α1 subunits, α1G (Cav3.1), α1H (Cav3.2) or α1I
(Cav3.3) [14]. We performed RT-PCR to investigate
whether the expression of TCC subunits is changed after
chronic constriction injury (CCI). In the current study,
the Cav3.1 expression in ACC was too low to be quanti-
fiable. Compared to the sham group, the expression of
Cav3.2 was higher in the CCI group (Sham: 1.0 ± 0.07,
n = 10 vs. CCI: 1.2 ± 0.08, n = 10, P = 0.043 using the nor-
mal Student’s t test; Figure 1A, B). Meanwhile, there was
no significant difference in the expression of Cav3.3 be-
tween the two groups. Next we further validated the
presence of TCCs by in vitro electrophysiological experi-
ments. We evoked an inward current using the TCCFigure 1 The expression of TCCs in rat ACC. A, Quantitative Real-time P
TCC subunits between the Sham and CCI groups. *P < 0.05 compared to th
pyramidal cell of ACC. Black trace representing the T-type current evoked b
the attenuated current after NNC 55–0396 (a selective TCC inhibitor, 20 μM
of inhibition ratio of NNC 55–0396 on T-type currents between the Sham and
a burst firing elicited by a transient current injection, and the red trace rep
NNC 55–0396 bath application. Scale bars: 20 pA/25 mV and 100 ms.determination methods [15] in ACC pyramidal cells
(Figure 1C). Moreover, the current was attenuated by
NNC 55–0396, a selective TCC inhibitor [16]. However,
we found that there was no significant difference in the
inhibition ratio between the Sham and CCI groups
(Figure 1D). Because the TCC is considered to contrib-
ute to the bursting activity, we investigated whether
NNC 55–0396 could affect the bursting. We found that
the elicited burst firing was attenuated by the TCC in-
hibitor (Figure 1E).
We next compared the intrinsic properties of TCCs
between sham animals and CCI animals. We found that
the T-type currents were greater in the CCI group
(Sham: Imax = 110.1 ± 12.83 pA, n = 12 vs. CCI: Imax =
188.8 ± 22.54 pA, n = 15, P = 0.016 using the normal Stu-
dent’s t test; Figure 2A, B), and this result was consistent
with the upregulation in TCC expression. However, the
activation and inactivation kinetics were not significantly
different between the two groups (Figure 2C-F). These
data indicate that TCCs are normally embedded in theCR standard curves and melt culves. B, Comparison of RNA levels of
e Sham group. NS, not significant. C, Induction of T-type currents in a
y transient membrane depolarization, and the red trace representing
) bath application. Scale bars: 20 pA/35 mV and 25 ms. D, Comparison
CCI groups. E, TCC mediated burst firing in ACC. Black trace representing
resenting a single spike elicited by the same current injection after
Figure 2 Effect of CCI on intrinsic properties of TCCs in the ACC.
A, Induction of T-type currents with ascending depolarization from a
sham (black) animal and a CCI (red) animal. Scale bars: 50 pA/80 mV
and 50 ms. B, Comparison of maximum T-type current between
the Sham and CCI groups. *P < 0.05 compared to the Sham group.
C, Steady-state activation of T-type currents recorded from ACC
pyramidal cells. D, Comparison of half-activation potential of TCC
between the Sham and CCI groups. NS, not significant. E, Steady-state
inactivation of T-type currents recorded from ACC pyramidal cells.
F, Comparison of half-inactivation potential of TCC between the
Sham and CCI groups.
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lated after CCI surgery.
Synaptic transmission in the ACC was attenuated by the
TCC inhibitor
Xu et al. have demonstrated that both pre- and postsyn-
aptic transmission was potentiated in the ACC after CCI
surgery [6]. Further, such synaptic plasticity is respon-
sible for generating neuropathic pain [7]. To confirm
whether the TCC inhibitor affects synaptic transmissionin the ACC, we investigated the amplitude and frequency
of miniature excitatory postsynaptic currents (mEPSCs) in
the brain slices before and after NNC 55–0396 application.
Consistent with previous studies, significant enhance-
ments were found in the frequency (Sham: n = 9, 1.2 ±
0.13 Hz vs. CCI: n = 8, 1.8 ± 0.12 Hz, P = 0.003 using the
normal Student’s t test; Figure 3A-B) and the amplitude
(Sham: 9.7 ± 0.83 pA vs. CCI: 12.9 ± 1.29 pA, P = 0.03
using the Mann–Whitney Rank Sum Test; Figure 3C) of
mEPSCs in ACC neurons after CCI surgery. NNC 55–
0396 significantly reduced the frequency (Sham: n = 9,
1.2 ± 0.13 Hz vs. 0.7 ± 0.12 Hz, P = 0.004 using the nor-
mal paired t test; CCI: n = 8, 1.8 ± 0.12 Hz vs. 1.1 ± 0.18
Hz, P = 0.005 using the normal paired t test; Figure 3D)
but not the amplitude (Figure 3E) of the mEPSCs in both
Sham and CCI groups. However, there were no significant
differences in the inhibition ratio of frequency or in the
amplitude between Sham and CCI groups (Figure 3F, G).
These results indicate that the TCC inhibitor regulates
presynaptic transmission more than postsynaptic trans-
mission and that there is no difference between the Sham
and CCI groups.
ACC neuronal activity was reduced by the TCC inhibitor
Our previous work revealed that the neuronal activity in
the ACC was facilitated after CCI surgery [8]. In the
current study, we found that focal application of TCC
inhibitor could significantly reduce the action potential
frequency of ACC pyramidal cells in CCI rats (Saline:
n = 6 vs. NNC 55–0396: n = 6, overall P < 0.001 using two-
way ANOVA followed by Bonferroni’s t-test; Figure 4A, B).
This change in the frequency of action potentials accom-
panied the reduction in burst events (overall P = 0.002
using two-way ANOVA followed by Bonferroni’s t-test;
Figure 4C).
Microinjection with TCC inhibitor relieves mechanical and
thermal allodynia
To assess whether inhibiting TCCs in rat ACC could al-
leviate neuropathic pain, we compared the thresholds of
mechanical and thermal allodynia before and after ACC
microinjection with NNC 55–0396. First, we confirmed
the microinjection site with hematoxylin and eosin stain-
ing (Figure 5A). One week after cannulation, CCI sur-
gery was performed (the day of surgery is considered
D0), and tests of the threshold of mechanical and ther-
mal allodynia on D7 demonstrated that the modeling
was successful (Figure 5B). Then, we divided the animals
into equal groups for Saline and NNC 55–0396 treat-
ment (Figure 5C, D). The drug tests were performed on
D10, when the mechanical and thermal allodynia had
formed stably. NNC 55–0396 significantly relieved the
mechanical (Saline: n = 10, 2.7 ± 0.46 vs. 2.8 ± 0.33, P =
0.750 using the paired t test followed by Wilcoxon
Figure 3 Effect of TCC inhibitor on synaptic transmission of the ACC. A, Representative mEPSCs recorded in ACC neurons from Sham (black)
and CCI (red) groups at a holding potential of −70 mV. Scale bars represent 20 pA and 1 sec. B, Comparison of frequency of mEPSCs between
the Sham and CCI groups. **P < 0.01 compared to the Sham group. C, Comparison of amplitude of mEPSCs between the Sham and CCI groups.
*P < 0.05 compared to the Sham group. D, Effect of NNC 55–0396 (20 μM) on frequency of mEPSCs. **P < 0.01 compared to the values before
drug application. E, Effect of NNC 55–0396 on amplitude of mEPSCs. NS, not significant. F, Inhibition ratio of NNC 55–0396 on frequency of
mEPSCs. G, Inhibition ratio of NNC 55–0396 on amplitude of mEPSCs.
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7.3 ± 0.94, P = 0.002 using the paired t test followed by
Wilcoxon Signed Rank Test; Figure 5E) and thermal (Sa-
line: n = 10, 16.5 ± 0.79 vs. 17.0 ± 0.77, P = 0.473 using
the normal paired t test; NNC 55–0396: n = 10 15.7 ±
0.95 vs. 24.6 ± 2.50, P = 0.004 using the normal paired t
test; Figure 5F) allodynia 30 min after ACC microinjec-
tion. We also observed that the analgesic effects of NNC
55–0396 were temporary: the thresholds of mechanical
and thermal allodynia reverted to the base values on
D14 (data not shown). To clarify the effective drug dur-
ation of NNC 55–0396, we tested the thresholds of
mechanical and thermal allodynia over the course of 24
hours. The thresholds of mechanical (−0.5 h: 2.6 ± 0.44,n = 8 vs. 1 h: 7.0 ± 0.54, n = 8, P < 0.001 using one-way
ANOVA followed by the Holm-Sidak post hoc test;
Figure 5G) and thermal (−0.5 h: 17.5 ± 0.42, n = 8 vs. 1 h:
26.9 ± 1.65, n = 8, P < 0.01 using one-way ANOVA
followed by Dunn’s Method; Figure 5H) allodynia both
peaked at 1 h after ACC microinjection, and they both
reverted to the base values within 3 h.
Discussion
Todorovic and colleagues have demonstrated that CCI-
induced neuropathy significantly increases T-type current
expression in small dorsal root ganglion (DRG) neurons
[15]. Moreover, intraperitoneal or intrathecal administra-
tion of TCC inhibitors has been shown to relieve the
Figure 4 Effect of TCC inhibitor on neuronal activity of ACC pyramidal cells in CCI rats. A, Voltage traces showing the firing of ACC pyramidal
cells in Saline (black) group and NNC 55–0396 (red, 0.1 μg/kg) group before and 30 min after drug application by in vivo patch-clamp recording. Gray
dash lines indicating the potential level of −60 mV. Scale bars: 10 mV and 1 sec. B, Effect of NNC 55–0396 focal application on frequency of action
potentials in ACC pyramidal cells. The frequency of action potential was sorted out from every time frame of 10 min. The drug application (▲) was
performed after 10 min base recording. Data are presented over time as normalized values. *P < 0.05, **P < 0.01 compared to the Saline group. C, Effect
of NNC 55–0396 focal application on frequency of burst events in ACC pyramidal cells. *P < 0.05, compared to the Saline group.
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some of the pain-associated brain regions, such as the
thalamus and hypothalamus [21,22]. Therefore, the effects
of systematical administration of TCC inhibitors on those
brain regions cannot be ignored because some TCC inhib-
itors, such as ethosuximide, which is approved for clinical
treatment of absence seizure, can pass through the blood–
brain barrier [23]. Chen et al. have demonstrated that
intracerebroventricular injection of TCC inhibitors could
alleviate acid-induced chronic muscle pain [24]. These
results suggest that modulating brain TCCs for treating
neuropathic pain is feasible.
More and more evidence has shown that the ACC
plays an important role in neuropathic pain [25-29]. We
therefore speculated that modulating TCCs in ACC
might alleviate neuropathic pain. In the current study,
we found that at least two subunits (Cav3.2 & Cav3.3) of
the TCC are present in the ACC and that the RNA level
of Cav3.2 was upregulated in a CCI model. This is con-
sistent with the standpoint that Cav3.2 supports thedevelopment and maintenance of both physiological and
pathological pain [30]. Moreover, we found that that the
T-type current intensity was increased when the CCI
model was established stably. However, the activation
and inactivation kinetics did not change significantly.
These results are also consistent with reports of the
studies on the peripheral nervous system [15]. Our re-
sults indicate that TCCs in the ACC may contribute to
the maintenance of neuropathic pain.
Recent studies have demonstrated that TCCs regulate
presynaptic neurotransmitter release [30-32], and our
results support this standpoint. Because ACC synaptic
plasticity is responsible for neuropathic pain generation
[7], it is reasonable to use TCC inhibitors for pain man-
agement. However, Kang et al., using multi-electrode
array recordings, reported that TCC had no contribution
to the glutamatergic excitatory synaptic transmission in
the ACC [13]. Kang’s study revealed that the contribu-
tion of TCCs in the ACC was no more than 5% in
normal animals, whereas our study found that for all
Figure 5 Effect of ACC microinjection with TCC inhibitor on mechanical and thermal allodynia. A, An example of microinjection site in an
ACC slice with hematoxylin and eosin staining. The area in red dashed line indicating ACC, and the black arrow indicating lateral ventricle (LV).
B, Experimental time schedule. D0 refer to the day of CCI surgery. C-D, Assessing the effect of CCI surgery. The stuffed bars representing the values
before CCI surgery, whereas the hollow bars representing the values on D7. ***P < 0.001 compared to the values before CCI surgery. E-F, Comparison
of the effect of Saline and NNC 55–0396 (0.1 μg/kg) microinjection on mechanical and thermal allodynia. Black symbol representing the Saline group,
and red symbol representing NNC 55–0396 group. The drug effect was investigated 30 min after ACC microinjection on D10. **P < 0.01 compared to
the values before ACC microinjection. NS, not significant. G-H, Effective drug duration of NNC 55–0396 single treatment on mechanical and
thermal allodynia. Horizontal ordinate representing the relative time of ACC microinjection.▲: Drug application. *P < 0.05 compared to the
values before microinjection.
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40% in presynaptic transmission. This discrepancy may
arise from the differences in the study design.
Beacause our previous work demonstrated that the
neuronal activity in the ACC is upregulated with CCI
[8], we therefore supposed that pain perception might be
reduced by inhibiting the neuronal activity of the ACC.First, we demonstrated that local application of TCC in-
hibitors could suppress the neuronal activity of the ACC
in vivo. Then, we tested the effect of the drug on pain
behavior. As expected, both mechanical and thermal
allodynia were partially relieved by ACC microinjection
with a TCC inhibitor, and the effect was temporary (<3 h).
These results are indicating that neuropathic pain may be
Table 1 Primer sequences of β-actin, Cav3.1, Cav3.2 and
Cav3.3
Gene Primer sequences Product size (bp)
GAPDH 194
Forward 5’- TATCGGACGCCTGGTTAC -3’
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modulating the TCCs.
Some limitations of the current study must also be
considered. For T-type currents and synaptic transmis-
sion, we found the effect of the TCC inhibitor did not
differ between the Sham and CCI groups. This result in-
dicates that the pain threshold in both sham and CCI
animals may be regulated by TCC inhibitor. However,
the finding that TCC inhibitors may affect the pain per-
ception in normal condition does not preclude the fact
that ACC microinjection with TCC inhibitors relieves
mechanical and thermal allodynia.
Conclusions
Considering our results, we suggest that TCCs in the
ACC may contribute to the maintenance of neuropathic
pain and systemic administration of TCC inhibitors may
have a partial effect on painassociated brain regions (e.g.,
the ACC) for the treatment of neuropathic pain.
Methods
Animals and modeling
Sprague–Dawley rats aged 9–11 weeks and weighing
250–350 g (Shanghai Sipper–BK Laboratory Animals
Co., Ltd, Shanghai, China) were raised in cages at 24°C
and 50%-60% humidity in a 12 h/12 h light/dark cycle
with sufficient food and water supplied. All surgical pro-
cedures were performed under anesthesia with intraperi-
toneal injection of pentobarbital sodium (40 mg/kg).
The research protocol was approved by the Animal Use
and Care Committee for Research and Education of
Shanghai Jiao Tong University. The number of animals
used in this study met the minimum requirement for the
purpose of the study.
The chronic constriction injury (CCI) model was
established in accordance with the method described by
Bennett [33]. In brief, the left sciatic nerves were ex-
posed unilaterally after skin incision at the mid-thigh
level and blunt dissection at the biceps. Four chromic
gut (5–0) ligatures were tied loosely around the nerve at
a 1–mm interval, proximal to its trifurcation. The day of
surgery is considered day 0 (D0). The animals with paw
withdrawal thresholds < 8 g or paw withdrawal latency <
20 s on D7 were considered successful for modeling
neuropathic pain. Sham surgery was performed by ex-
posing the sciatic nerve without ligation. The animals
were used for experiments from D7 to D14.
Mechanical and thermal allodynia test
For mechanical allodynia test, the animals were habitu-
ated for 2–3 days in the test environment before each
test. The rats were placed in a plexiglass box with a
metal net bottom for 30 min. After habituation to the
environment, the hind paw was stimulated with one of aseries of von Frey hairs with logarithmically increasing
stiffness (0.6, 1, 1.4, 2, 4, 6, 8, 10, and 15 g) (Stoelting),
presented perpendicular to the plantar surface (5–6 s for
each hair). A positive performance was recorded when
the rat escaped the mild pressure or raised the hind leg.
Dixon’s up–down method was used to determine the
50% withdrawal threshold [34].
The thermal allodynia test used a different group of
rats from the mechanical allodynia test. The rats were
placed in a plexiglass box on a 3-mm-thick glass plate.
After habituation in the box for 30 min, the sole skin of
the animal was irradiated with light within a circle of 0.5
cm in diameter using a BME–410 thermal radiation
stimulator (Peking Union Medical College Institute of
Biomedical Engineering, China) at 10 V and 30 W. The
time from the initiation of irradiation to paw withdrawal
was recorded as the paw withdrawal latency value. Forty
seconds was used as the cut-off time to avoid local burn
injury. Three measurements were taken for each animal,
with a 6–8 min interval, and the mean value was used
for analysis.
Quantitative real-time PCR
Total RNA from ACC tissues was extracted using TRI-
zol (Takara Biotechnology Co., Ltd.). The isolated RNA
was subsequently treated with RNase-free DNase to re-
move genomic DNA contamination. cDNA was synthe-
sized according to the manufacturer’s instructions (Takara
Biotechnology Co., Ltd.). Primers (Table 1) were designed
using Oligo 6 Primer Analysis software (Molecular Biology
Insights Inc., Cascade, CO, USA). Each cDNA was amp-
lified with SYBR® Premix Ex Taq™ Kit (Takara Biotech-
nology Co., Ltd.). The cycling conditions were 35 cycles
of denaturation at 95°C for 30 seconds, primer anneal-
ing at 56°C for 30 seconds and primer extension at 72°C
for 24 seconds. Each sample was analyzed in triplicate.
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expression levels and quantified using the 2−ΔΔCt method.
In vitro patch-clamp recordings
Brain slices were prepared in a manner similar to the
one described by Xu et al. [6]. In brief, the animal was
anesthetized with sodium pentobarbitone, and the brain
was quickly excised from the skull and submerged in
ice-cold artificial cerebrospinal fluid (ACSF, in mM: 119
NaCl, 1.3 MgSO4, 2.5 KCl, 1 NaH2PO4, 26.2 NaHCO3,
2.5 CaCl2, and 11 D-glucose). After being chilled for 1–2
min, the brain was trimmed to a block containing the
ACC. With the use of a vibro-slicer (LEICA VT1000),
coronal slices (300–450 μm) were cut from the tissue
block in ice-cold ACSF. The slices were transferred to a
gas-interface recording chamber that was perfused with
aerated (95% O2/5% CO2) ACSF, at a rate of 0.5–1 ml/
min, by a peristaltic pump-driven or gravity-fed bath-
perfusion system at room temperature (22°C). Constant
temperature (22°C), humidified 95% O2/5% CO2 gas
mixture was continuously blown over the slices to fur-
ther ensure adequate oxygenation of cells in the tissue.
Current- or voltage-clamp recordings were obtained
from pyramidal cells in layer II/III of the ACC slices
after equilibration for 1–2 h in the recording chamber.
Whole cell recordings (series resistances: 15–22 MΩ) of
TCCs were obtained with micropipettes (tip diameter:
1.5-2.0 μm; resistance: 4–5 MΩ) that were filled with an
internal solution composed of (in mM): 140 K-gluconate,
10 HEPES, 2 MgCl2, 1 CaCl2, 11 EGTA, 2 K2ATP, pH 7.3.
Normal ACSF, containing (in μM) 30 bicuculline methio-
dide, 2 nimodipine, 3 ω-conotoxin MVIIC, 0.5 tetrodo-
toxin, was used as the external solution in studying T-type
currents [35]. The voltage errors resulting from the series
resistance were compensated offline for voltage-clamp
recordings and online for current-clamp recordings by
using the bridge circuit. The signals from neurons were
amplified with an Axoclamp-700B amplifier (bandwidth
filter set at 10 kHz for current-clamp and 1 kHz for
voltage-clamp recordings) and then digitized and sam-
pled at 50-μs intervals (Digidata 1440A, pClamp 10.2;
Molecular Devices).
The activation/inactivation kinetic curves were fitted with
the Boltzmann equation: I/Imax = 1/{1 + exp[(V – V1/2)/k]},
where Imax is the maximum current obtained, V1/2 is the
half-activation/inactivation potential and k is the steepness
constant.
In vivo patch-clamp recording
Animals were initially anesthetized with urethane (1.2 g/
kg; intraperitoneally). After tracheotomy, the head was
restrained in a stereotaxic apparatus (David Kopf Instr.)
with the body temperature maintained at 37.3-37.8°C.
For recording, a small craniotomy (~2 mm in diameter)was made above the left cortex, and a small piece of
dura mater was carefully removed. Electrophysiological
recordings were conducted at a light anesthesia level just
below the threshold of body movements consisting of
licking or scratching.
The micropipettes (tip diameter: 2.5-3.0 μm; resist-
ance: 3–4 MΩ) were filled with an internal solution con-
taining (in mM) 136.5 K-Gluconate, 17.5 KCl, 9.0 NaCl,
1.0 MgCl2, 10.0 HEPES, 0.2 EGTA, and Amphotericin B
(0.5 mg/ml). The pH of the internal solution was adjusted
to 7.3. Signals were acquired with an Axoclamp-200B
amplifier, and sampled at 5 or 10 kHz using a Digidata
1440A with 1, 2, or 5 kHz low-pass filtering. The position
of the ACC region was fixed by the stereotaxic coordi-
nates (from Bregma, 1.2-2.8 mm anterior, 0.2-0.6 mm lat-
eral; 1.5-2.0 mm beneath the cortical surface). For ACC
local infusion, glass pipettes full of saline or NNC 55–0396
(0.1 μg/kg) with tip openings of ~50 μm were used, and
they were placed within ~100 μm of the recording pipettes.
The action potentials were detected using Threshold
Research, and the burst firings were detected using Burst
Analysis. Minimum events in burst = 2, Burst delimiting
interval = 100 ms (pClamp 10.2).
Cannulation and microinjection
The rats were anesthetized with sodium pentobarbital
and secured on the stereotaxic apparatus. A midline in-
cision was made to expose the skull of the rat. Based on
the position determined by the stereotaxic atlas, 28
gauge guide cannulas were bilaterally implanted in the
ACC at the following coordinates: 2.7 mm anterior from
bregma, ± 0.6 mm lateral to midline, and 2.0 mm ventral
from the dura; 0.4 mm anterior from bregma, ± 0.6 mm
lateral to midline, and 2.0 mm ventral from the dura.
Around the guide cannulas, three stainless screws were
implanted into the skull and fixed with dental acrylic.
The dummy cannulas were inserted after surgery until
the infusion day. CCI was performed immediately after
cannulation. The animals were raised individually after
surgery. The dummy cannulas were pulled out before
microinjection. The internal injection cannulas (32 gauge),
extending 1 mm beyond the guide cannulae, were inserted.
Saline or NNC 55–0396 (0.1 μg/kg) was injected at a con-
stant rate for longer than 120 s with a micro-injector. The
injection cannulas were left in place for an additional 3 min
before being withdrawn. The animals were allowed to move
freely during the entire injection process. An additional 30
min was given before the beginning of behavioral test.
Microinjection was performed on D10.
Drugs
All drugs were purchased from Sigma, and they were
diluted from the stock solutions to the final desired con-
centration in the ACSF or saline immediately before use.
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Numerical data are expressed as the mean ± S.E.M. Stu-
dent’s t test was used for the comparison of two inde-
pendent datasets with normal distribution, whereas the
paired t test and Wilcoxon Signed Rank Test were per-
formed for comparisons of two dependent datasets with
and without normal distribution, respectively. One-way
ANOVA and pairwise comparison with the Holm-Sidak
test were performed to compare multiple independent
datasets with normal distributions, whereas Kruskal-
Wallis one-way ANOVA on ranks was performed to
compare datasets without normal distributions. Two-way
ANOVA with Bonferroni’s post hoc test was performed to
determine wheter there was a contingency between the two
kinds of classification. P <0.05 was considered significant.
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